Journal of Medicinal Chemistry p. 352 - 356 (1988)
Update date:2022-09-26
Topics: Chemical Synthesis Clinical Trials Regulatory Approval Pharmacokinetic Studies Toxicity and Safety Evaluation Biological Activity Testing Spectroscopic Characterization
Howson, W.
Kitteringham, J.
Mistry, J.
Mitchell, M. B.
Novelli, R.
et al.
6-<4-<3-<<2-Hydroxy-3-<4-<2-(cyclopropylmethoxy)ethyl>phenoxy>propyl>amino>propionamido>phenyl>-5-methyl-4,5-dihydro-3(2H)-pyridazinone (3) consists of a mixture of four stereoisomers, i.e., two racemates, as aconsequence of the two asymmetric centers con
View MoreChengdu CSH Pharmaceutical Co.,ltd
Contact:+86-(28)-85321971
Address:Block B,New Hope Int. Tian Fu New District, Chengdu, Sichuan, China
Jinan Yijialian Economic and Trade Development Co., Ltd.
Contact:+86 0531-66729596
Address:jinan
Wuhan Hanye Chemical New Material Co.,Ltd
Contact:+86-27-85308141
Address:LiuDian, Panlongcheng Economic Development Zone, HuangPi district, Wuhan, Hubei 430311 P.R.China
website:http://www.china-sinoway.com
Contact:+86-592-5853819
Address:16/F,Huicheng Comm,Complex,No839 XiaHe Rd, Xiamen,China
Contact:+86-574- 87178138; 87297407
Address:No. 809, Liudingxingzuo, cangsong road, Ningbo, China
Doi:10.1021/jo01074a027
(1960)Doi:10.1002/(SICI)1096-9063(199911)55:11<1116::AID-PS65>3.0.CO;2-Y
(1999)Doi:10.1016/j.tet.2008.10.109
(2009)Doi:10.1021/jo800950y
(2008)Doi:10.1021/ja710749q
(2008)Doi:10.1016/j.bmc.2015.08.005
(2015)
